Clinical Trials

NCT04707651 | ACTIVE_NOT_RECRUITING | NA
20 participants

Formula Diet Treatment for NASH Patients.

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-04
Start Date:
2021-01-18
Completion:
2027-12-31
Conditions
  • Steatohepatitis, Nonalcoholic
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT04669743 | ACTIVE_NOT_RECRUITING | NA
72 participants

Innate Immunity in Ozone-induced Airway Inflammation in COPD

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-04
Start Date:
2016-04-07
Completion:
2030-12-31
Conditions
  • Pulmonary Disease, Chronic Obstructive
  • Airway Disease
  • COPD Exacerbation
  • Pollution; Exposure
  • Pollution Related Respiratory Disorder
Interventions
  • OTHER
No Results Yet
NCT04630431 | TERMINATED | NA
590 participants

Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-04
Start Date:
2019-10-15
Completion:
2022-04-12
Conditions
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
Interventions
  • OTHER
  • BEHAVIORAL
No Results Yet
NCT04621435 | RECRUITING | PHASE1
191 participants

Imaging of Solid Tumors Using FAP-2286

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-04
Start Date:
2020-12-14
Completion:
2026-12-31
Conditions
  • Solid Tumors, Adult
  • Metastatic Cancer
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT04573478 | ACTIVE_NOT_RECRUITING | PHASE3
404 participants

Atrasentan in Patients With IgA Nephropathy

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-04
Start Date:
2020-12-11
Completion:
2028-04-14
Conditions
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
Interventions
  • DRUG
No Results Yet
NCT04566393 | AVAILABLE

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Study Type:
EXPANDED_ACCESS
Last Updated:
2026-06-04
Conditions
  • Pancreatic Cancer
  • Small Bowel Cancer
  • Colorectal Cancer
  • Melanoma
  • Non Small Cell Lung Cancer
  • Thyroid Cancer
  • Bladder Cancer
  • Head and Neck Cancer
  • Gastric Cancer
  • Esophageal Cancer
  • Cholangiocarcinoma
  • Ovarian Cancer
  • Hepatocellular Carcinoma
  • Glioblastoma
  • MAPK Gene Mutation
  • KRAS Activating Mutation
  • BRAF Gene Mutation
  • NRAS Gene Mutation
  • HRAS Gene Mutation
  • MEK Mutation
  • ERK Mutation
Interventions
  • DRUG
No Results Yet
NCT04468659 | ACTIVE_NOT_RECRUITING | PHASE3
1400 participants

AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-04
Start Date:
2020-07-14
Completion:
2028-12-21
Conditions
  • Preclinical Alzheimer's Disease
  • Early Preclinical Alzheimer's Disease
Interventions
  • DRUG
No Results Yet
NCT04339036 | RECRUITING | PHASE2
70 participants

CapTemY90 for Grade 2/3 NET Liver Metastases

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-04
Start Date:
2021-10-07
Completion:
2028-07-01
Conditions
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumors
Interventions
  • DRUG
  • COMBINATION_PRODUCT
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page